SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002396
Filing Date
2022-08-12
Accepted
2022-08-12 16:07:25
Documents
53
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acxp-20220630x10q.htm   iXBRL 10-Q 1211239
2 EX-31.1 acxp-20220630xex31d1.htm EX-31.1 11951
3 EX-31.2 acxp-20220630xex31d2.htm EX-31.2 11959
4 EX-32.1 acxp-20220630xex32d1.htm EX-32.1 4825
5 EX-32.2 acxp-20220630xex32d2.htm EX-32.2 4845
  Complete submission text file 0001410578-22-002396.txt   3864695

Data Files

Seq Description Document Type Size
6 EX-101.SCH acxp-20220630.xsd EX-101.SCH 35033
7 EX-101.CAL acxp-20220630_cal.xml EX-101.CAL 18598
8 EX-101.DEF acxp-20220630_def.xml EX-101.DEF 142248
9 EX-101.LAB acxp-20220630_lab.xml EX-101.LAB 267456
10 EX-101.PRE acxp-20220630_pre.xml EX-101.PRE 242977
47 EXTRACTED XBRL INSTANCE DOCUMENT acxp-20220630x10q_htm.xml XML 327930
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40536 | Film No.: 221160105
SIC: 2834 Pharmaceutical Preparations